Disclosure of interest: Seyyed Sina Hejazian: nothing to disclose - Alireza Vafaei Sadr: nothing to disclose - Ajith Vemuri: nothing to disclose - Vida Abedi: nothing to disclose - Ramin Zand: nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.02 - LIFE AFTER STROKE P2228 - ESOC25-911 NEUROPSYCHIATRIC SEQUELAE AND COGNITIVE DEFICITS AFTER STROKE WITH THROMBECTOMY AND GOOD FUNCTIONAL OUTCOME (NESCAT): PRELIMARY RESULTS Naomi Giesers 1,2 , Constanze Buschmann 3 , Mandy Roheger 3 , Rachana Mahadevan 3 , Karsten Witt 1,2 , Thomas Liman 1,2,4 1 Neurology, Carl von Ossietzky-University Oldenburg, Oldenburg, Germany, 2 Evangelical Hospital Oldenburg, Oldenburg, Germany, 3 Department of Psychology, Carl von Ossietzky University Oldenburg, Oldenburg, Germany, 4 Charit, Berlin, Germany Background and Aims: Endovascular thrombectomy (EVT) significantly improves functional recovery following stroke, but cognitive deficits and neuropsychiatric sequelae in patients with favorable outcomes remain underexplored
When Semax is paired with the Wolverine Blend, the result is a morning/night split schedule with no timing conflict between the two compounds
He had a new treatment protocol and was feeling optimistic
How BPC-157 and TB-500 Compare at a Glance BPC-157 and TB-500 are frequently discussed together because both are promoted for recovery and both act, in part, through angiogenesis (the growth of new blood vessels)
Whether these rapid responses reflect true biological effects or placebo components remains difficult to distinguish
